Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|
Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|---|---|---|---|---|---|---|---|
Q4 2024 | 118 | $4.32B | +$152M | -$867M | -$715M | CYBR, GKOS, DDOG, MANH, VCEL | 13F-HR | 2/14/2025, 01:04 PM |
Q3 2024 | 133 | $4.65B | +$52.5M | -$806M | -$753M | GWRE, MANH, TYL, GKOS, CYBR | 13F-HR | 11/12/2024, 08:58 AM |
Q2 2024 | 130 | $4.95B | +$158M | -$527M | -$369M | GWRE, MANH, DDOG, TYL, GKOS | 13F-HR | 8/12/2024, 04:22 PM |
Q1 2024 | 133 | $5.65B | +$222M | -$1.39B | -$1.17B | APPF, MANH, VEEV, DDOG, VCEL | 13F-HR | 5/15/2024, 08:14 AM |
Q4 2023 | 128 | $6.66B | +$264M | -$831M | -$567M | DDOG, SMAR, GWRE, VEEV, ANSS | 13F-HR | 2/14/2024, 09:00 AM |
Q3 2023 | 126 | $6.52B | +$102M | -$229M | -$126M | APPF, VEEV, MANH, ALRM, DDOG | 13F-HR | 11/14/2023, 02:08 PM |
Q2 2023 | 126 | $7.05B | +$236M | -$497M | -$261M | MANH, APPF, DDOG, ANSS, TYL | 13F-HR | 8/14/2023, 03:43 PM |
Q1 2023 | 124 | $6.69B | +$413M | -$355M | +$58.3M | ANSS, APPF, MANH, VEEV, PAYC | 13F-HR | 5/15/2023, 09:00 AM |
Q4 2022 | 128 | $6.05B | +$571M | -$1.13B | -$559M | PAYC, MANH, APPF, CGNX, TYL | 13F-HR | 2/14/2023, 09:00 AM |
Q3 2022 | 124 | $7.13B | +$277M | -$381M | -$104M | MANH, PAYC, TYL, ALRM, APPF | 13F-HR | 11/14/2022, 09:00 AM |
Q2 2022 | 124 | $7.47B | +$577M | -$799M | -$222M | MANH, VEEV, TYL, PAYC, ALRM | 13F-HR | 8/15/2022, 09:19 AM |
Q1 2022 | 127 | $10B | +$465M | -$794M | -$329M | CGNX, TYL, DDOG, MANH, PAYC | 13F-HR | 5/16/2022, 09:06 AM |
Q4 2021 | 129 | $12.1B | +$366M | -$695M | -$329M | TYL, DDOG, MANH, CGNX, PAYC | 13F-HR | 2/14/2022, 01:29 PM |
Q3 2021 | 127 | $12.2B | +$252M | -$1.04B | -$785M | PAYC, DDOG, TYL, MANH, CGNX | 13F-HR | 11/15/2021, 11:52 AM |
Q2 2021 | 122 | $13.2B | +$791M | -$1.5B | -$711M | CGNX, VEEV, TYL, MANH, PAYC | 13F-HR | 8/16/2021, 04:28 PM |
Q1 2021 | 127 | $13.4B | +$372M | -$496M | -$124M | CGNX, MANH, PAYC, TYL, VEEV | 13F-HR | 5/14/2021, 08:32 AM |
Q4 2020 | 124 | $14.5B | +$115M | -$206M | -$90.7M | PAYC, CGNX, TYL, IRTC, VEEV | 13F-HR | 2/16/2021, 11:45 AM |
Q3 2020 | 117 | $12.1B | +$257M | -$463M | -$207M | VEEV, IRTC, CGNX, MANH, PAYC | 13F-HR | 11/13/2020, 08:16 AM |
Q2 2020 | 118 | $11.6B | +$746M | -$1.01B | -$269M | QDEL, VEEV, AYX, MANH, CGNX | Restatement | 8/7/2020, 09:46 AM |
Q1 2020 | 114 | $8.63B | +$306M | -$509M | -$203M | VEEV, TYL, QDEL, NEOG, CGNX | 13F-HR | 5/8/2020, 12:17 PM |
Q4 2019 | 120 | $10.5B | +$150M | -$518M | -$369M | TYL, PAYC, CGNX, VEEV, MANH | 13F-HR | 2/14/2020, 12:45 PM |
Q3 2019 | 121 | $10.3B | +$491M | -$365M | +$126M | VEEV, TYL, MANH, PAYC, CGNX | 13F-HR | 11/13/2019, 08:39 AM |
Q2 2019 | 120 | $10.5B | +$989M | -$1.09B | -$96.8M | PAYC, VEEV, CGNX, MANH, PRLB | 13F-HR | 8/13/2019, 08:30 AM |
Q1 2019 | 123 | $9.89B | +$297M | -$422M | -$125M | PAYC, VEEV, CGNX, MANH, TYL | 13F-HR | 5/15/2019, 11:39 AM |
Q4 2018 | 122 | $8.31B | +$434M | -$446M | -$11.4M | PAYC, PRLB, VEEV, ABMD, TYL | 13F-HR | 2/14/2019, 09:24 AM |
Q3 2018 | 124 | $11B | +$468M | -$399M | +$68.8M | PAYC, PRLB, VEEV, ABMD, CGNX | 13F-HR | 11/14/2018, 10:32 AM |
Q2 2018 | 126 | $9.75B | +$396M | -$413M | -$16.8M | ABMD, NEOG, TYL, PRLB, BLKB | 13F-HR | 8/14/2018, 09:14 AM |
Q1 2018 | 129 | $8.81B | +$338M | -$252M | +$86.1M | NEOG, PAYC, BLKB, PRLB, TYL | 13F-HR | 5/15/2018, 09:25 AM |
Q4 2017 | 130 | $8.24B | +$267M | -$437M | -$170M | NEOG, BLKB, CGNX, PRLB, MANH | 13F-HR | 2/14/2018, 09:20 AM |
Q3 2017 | 129 | $8.22B | +$88.1M | -$395M | -$307M | CGNX, BLKB, MDSO, NEOG, TYL | 13F-HR | 11/14/2017, 09:17 AM |
Q2 2017 | 128 | $8.16B | +$409M | -$373M | +$36.5M | MDSO, BLKB, CGNX, VEEV, TYL | 13F-HR | 8/14/2017, 09:08 AM |
Q1 2017 | 126 | $7.5B | +$279M | -$273M | +$5.53M | CGNX, BLKB, VEEV, NEOG, TYL | 13F-HR | 5/9/2017, 08:44 AM |
Q4 2016 | 129 | $6.85B | +$476M | -$365M | +$111M | CGNX, NEOG, CMD, BLKB, MANH | 13F-HR | 2/8/2017, 12:35 PM |
Q3 2016 | 130 | $6.8B | +$307M | -$406M | -$99M | TYL, CGNX, BLKB, CMD, MDSO | 13F-HR | 11/14/2016, 09:28 AM |
Q2 2016 | 130 | $6.33B | +$228M | -$341M | -$113M | TYL, FEIC, BLKB, CMD, MDSO | 13F-HR | 8/4/2016, 10:47 AM |
Q1 2016 | 130 | $6.04B | +$525M | -$501M | +$24.6M | CMD, FEIC, TYL, BLKB, ANSS | 13F-HR | 5/16/2016, 11:36 AM |
Q4 2015 | 128 | $6.38B | +$292M | -$277M | +$15.5M | CMD, TYL, BLKB, NEOG, MANH | 13F-HR | 2/16/2016, 09:23 AM |
Q3 2015 | 130 | $5.84B | +$445M | -$260M | +$184M | CMD, MANH, TYL, ANSS, BLKB | 13F-HR | 11/16/2015, 09:18 AM |
Q2 2015 | 131 | $6.08B | +$118M | -$228M | -$110M | CMD, TYL, MANH, CGNX, MDSO | 13F-HR | 8/13/2015, 09:46 AM |
Q1 2015 | 130 | $6.06B | +$162M | -$176M | -$13.5M | CGNX, MANH, TYL, CMD, MDSO | 13F-HR | 5/15/2015, 09:45 AM |
Q4 2014 | 130 | $5.79B | +$531M | -$803M | -$272M | TYL, INCY, MDSO, CMD, NEOG | 13F-HR | 2/13/2015, 08:18 AM |
Q3 2014 | 125 | $5.65B | +$337M | -$333M | +$3.22M | NTCT, CGNX, MEAS, CNQR, MDSO | 13F-HR | 11/14/2014, 08:16 AM |
Q2 2014 | 137 | $6.01B | +$176M | -$267M | -$91.3M | NTCT, MEAS, FEIC, CGNX, CRRTQ | 13F-HR | 8/11/2014, 03:27 PM |
Q1 2014 | 139 | $6.07B | +$305M | -$80.9M | +$224M | FEIC, MANH, NTCT, MDSO, CRRTQ | 13F-HR | 5/13/2014, 11:40 AM |
Q4 2013 | 139 | $6.11B | $0 | $0 | MDSO, TYL, FEIC, CGNX, MANH | 13F-HR | 2/12/2014, 02:07 PM |